Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Qiwei Biotechnology is a specialized biotechnology firm focused on the development and production of advanced veterinary biologicals. Headquartered in the Changchun High-tech Industrial Development Zone, the company primarily serves the livestock industry with a focus on swine health. Their core expertise lies in recombinant subunit vaccines and high-efficiency expression systems for viral antigens. Jilin Qiwei's commercial portfolio includes vaccines for Classical Swine Fever and Porcine Circovirus, supported by modern GMP-certified manufacturing facilities. The company integrates research, development, and large-scale production to address critical infectious diseases in animal husbandry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Qiwei Biotechnology.